PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential
Pharmaceuticals · 27.04.2025 · 18 (5) · 631
DOI: 10.3390/ph18050631 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 27.04.2025. Verfasst von Hossein Omidian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Poly(lactide-co-glycolide) (PLGA) implants have become a cornerstone in drug delivery and regenerative medicine due to their biocompatibility, tunable degradation, and capacity for sustained, localized therapeutic release. Recent innovations in polymer design, fabrication methods, and functional modifications have expanded their utility across diverse clinical domains, including oncology, neurology, orthopedics, and ophthalmology. This review provides a comprehensive analysis of PLGA implant properties, fabrication strategies, and biomedical applications, while addressing key challenges such as burst release, incomplete drug release, manufacturing complexity, and inflammatory responses. Emerging solutions—such as 3D printing, in situ forming systems, predictive modeling, and patient-specific customization—are improving implant performance and clinical translation. Emphasis is placed on scalable production, long-term biocompatibility, and personalized design to support the next generation of precision therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.
ORCID-Profile: Hossein Omidian
Zitieren
APA
Omidian, H., & Wilson, R. L. (2025). PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential. Pharmaceuticals, 18(5), 631. https://doi.org/10.3390/ph18050631
Vancouver
Omidian H, Wilson RL. PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential. Pharmaceuticals. 2025;18(5):631. doi:10.3390/ph18050631
BibTeX
@article{Omidian2025,
author = {Omidian, Hossein and Wilson, Renae L},
title = {PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {5},
pages = {631},
doi = {10.3390/ph18050631}
}
EUVIMED